Identification of novel, selective and potent Chk2 inhibitors

A series of isothiazole carboxamidine compounds were synthesized and discovered as novel and selective inhibitors for Chk2. They are not active against the related Chk1 kinase. The structure-activity relationship studies were performed on the scaffold, and enzymatic kinetic analysis showed they are simple ATP competitive inhibitors with Ki values as low as 11 nM for Chk2. Computer modeling studies were employed to comprehend the mechanism of action and SAR of these compounds.

Graphical abstractNovel, selective and potent Chk2 inhibitors were identified. Their SAR and computer modeling studies were conducted.Figure optionsDownload full-size imageDownload as PowerPoint slide